Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Ciccarese

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Hepatology|April 11, 2014
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinomaAlessandro Cucchetti, Franco Trevisani, Anna Pecorelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 28, 2016
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinomaAnna Pecorelli, Barbara Lenzi, Annagiulia Gramenzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2013
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centresNora Cazzagon, Franco Trevisani, Gemma Maddalo, et al.
Journal of Hepatology|December 3, 2014
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre studyAlessandro Vitale, Patrizia Burra, Anna Chiara Frigo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 11, 2018
Metabolic disorders across hepatocellular carcinoma in ItalyFilomena Morisco, Maria Guarino, Maria R Valvano, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2016
The evolutionary scenario of hepatocellular carcinoma in Italy: an updateLaura Bucci, Francesca Garuti, Barbara Lenzi, et al.
Journal of Hepatology|February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinomaGiuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Plos Medicine|April 27, 2016
Development and Validation of a New Prognostic System for Patients with Hepatocellular CarcinomaFabio Farinati, Alessandro Vitale, Gaya Spolverato, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practiceEdoardo Giovanni Giannini, Laura Bucci, Francesca Garuti, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|April 11, 2014
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinomaAlessandro Cucchetti, Franco Trevisani, Anna Pecorelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 28, 2016
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinomaAnna Pecorelli, Barbara Lenzi, Annagiulia Gramenzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2013
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centresNora Cazzagon, Franco Trevisani, Gemma Maddalo, et al.
Journal of Hepatology|December 3, 2014
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre studyAlessandro Vitale, Patrizia Burra, Anna Chiara Frigo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 11, 2018
Metabolic disorders across hepatocellular carcinoma in ItalyFilomena Morisco, Maria Guarino, Maria R Valvano, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2016
The evolutionary scenario of hepatocellular carcinoma in Italy: an updateLaura Bucci, Francesca Garuti, Barbara Lenzi, et al.
Journal of Hepatology|February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinomaGiuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Plos Medicine|April 27, 2016
Development and Validation of a New Prognostic System for Patients with Hepatocellular CarcinomaFabio Farinati, Alessandro Vitale, Gaya Spolverato, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practiceEdoardo Giovanni Giannini, Laura Bucci, Francesca Garuti, et al.
Pageof 7